Status:
WITHDRAWN
Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
AD RescueWear
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
6-6 years
Phase:
NA
Brief Summary
Approximately 15-20% of children in the United States suffer from the symptoms of atopic dermatitis (eczema), which include pruritus, pain, irritation, and difficulty sleeping. Tencel fabric has been ...
Detailed Description
Atopic dermatitis (eczema) is a chronically recurrent, pruritic disorder most common in infants and young children. It is one of the most common pediatric dermatologic disorders, affecting 15-20% of a...
Eligibility Criteria
Inclusion
- Diagnosis of moderate or severe atopic dermatitis based on Eczema Area and Severity Index (EASI) score (moderate=6-22.9; severe=23-72)
- At least one active patch of atopic dermatitis at time of study
- Parent/guardian able to give informed consent
Exclusion
- Systemic medication or oral steroids within past 3 months (includes light therapy),
- Started new atopic dermatitis treatment regimen within the past month,
- Using wet/dry wraps \> once/week
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03843437
Start Date
July 1 2022
End Date
June 28 2024
Last Update
August 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Pediatric Dermatology Clinic
Baltimore, Maryland, United States, 21287